Zobrazeno 1 - 7
of 7
pro vyhledávání: '"N. Riolacci-Dhoyen"'
Autor:
Pierre Krolak-Salmon, Isabelle Rouch, V. Dauphinot, Caroline Roubaud, H. Finne-Soveri, A. Leperre-Desplanques, N. Riolacci-Dhoyen, Gaëlle Richard
Publikováno v:
European journal of neurology. 23(5)
Background and purpose Preventing behavioural crises appears to be crucial to promote quality of life of the patient−caregiver dyad, to reduce inappropriate hospitalizations and to delay institutionalization. The Alzheimer Cooperative Valuation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69c9e13910e879f99f78a05221b203d
https://pubmed.ncbi.nlm.nih.gov/26945537
https://pubmed.ncbi.nlm.nih.gov/26945537
Autor:
L Banaeï-Bouchareb, A Desplanques-Leperre, N Riolacci-Dhoyen, M Erbault, J.-L. Ducassé, E. Hinglais, Infarctus, P. Goldstein
Publikováno v:
BMJ Quality & Safety. 19:A20-A21
Background and Objectives Evidence-based medicine has brought about a marked improvement in the management of myocardial infarction with ST elevation (STEMI). STEMI is a high-priority health issue. Coronary reperfusion techniques are highly effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1788cc2d04355b9a0207c70bf885ae0
https://doi.org/10.1136/qshc.2010.041608.19
https://doi.org/10.1136/qshc.2010.041608.19
Autor:
P Ricordeau, N Riolacci-Dhoyen, L Banaeï-Bouchareb, M Erbault, V Le Corre, C Chan-Chee, A Desplanques-Leperre, J Deligne, B Lavallart, Groupe de Coopération Psychotropes
Publikováno v:
BMJ Quality & Safety. 19:A22-A23
Background and Objectives Neuroleptics (NL) are often prescribed to patients with Alzheimer9s disease (AD), mainly for behaviour disorders and during episodes of confusion. However, these drugs are known to have frequent and severe iatrogenic effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6915f5244e3597dfd73987f16b4eb543
https://doi.org/10.1136/qshc.2010.041608.21
https://doi.org/10.1136/qshc.2010.041608.21
Publikováno v:
BMJ Quality & Safety. 19:A21-A22
Background and Objectives Quality of care has three dimensions: efficacy (E), safety or management of care-related risks (S), and access to best care (A). These three dimensions are rarely taken into account simultaneously in quality initiatives. Cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a31132743a4d05afc11960eb60283fb5
https://doi.org/10.1136/qshc.2010.041608.20
https://doi.org/10.1136/qshc.2010.041608.20
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Barr C; Haute Autorité de Santé (HAS), Avenue du Stade de France, 93218, Saint-Denis La Plaine, France. c.barr@has-sante.fr., Riolacci-Dhoyen N, Galbraith M, Leperre-Desplanques A
Publikováno v:
Archives of public health = Archives belges de sante publique [Arch Public Health] 2012 Aug 28; Vol. 70 (1), pp. 21. Date of Electronic Publication: 2012 Aug 28.